Expanding Innovations Wins FDA Nod for N-GAGE Lumbar Plates

Expanding Innovations, a spine company specializing in non-screw-based expandable tech, has gained U.S. Food and Drug Administration (FDA) 510(k) clearance for its N-GAGE lumbar plate system, its first spinal fixation platform.

The company said the modular, low-profile architecture provides spine surgeons a flexible fixation tool for lateral and anterolateral lumbar fusions. The plate pairs with the company’s X-PAC LLIF expandable interbody cage system with a non-screw-based, polyaxial coupler.

Expanding Innovations said the connection simplifies plate-to-cage attachment and permits anatomical conformity to the vertebral bodies. This resolves the limitations of rigid, screw-based-attached lumbar plates.

“This regulatory milestone not only reflects our ongoing commitment to solving persistent challenges that exist in spine surgery,” said Ron Sacher, Expanding Innovations’ co-founder and executive chairman. “It represents the first of multiple upcoming technologies that will transition EI from a product-based technology company to a complete procedural solutions provider. N-GAGE unlocks new revenue opportunities and end-user value to complement our flagship, non-screw-based X-PAC expandable technology platform.”

The company’s X-PAC expandable cage system received FDA clearance in February 2023 and was subsequently launched in October of that year. X-PAC cages replace the inner implant drive screw with a patented lift and lock mechanism that provides tactile feedback throughout implant expansion, and implant locking once expansion is completed.

Over 15,000 X-PAC cages have been implanted in total, the company said.